Cancer, Hematologic disease,Collagen disease,
Conditions
Interventions
Patients undergo stimulation and in vitro fertilization(IVF) for fertility preservation before or in the course of treatment for primary disease. Combined therapy: one FSH/hMG injection(150-450 IU)pe
Sponsors
St. Marianna University of Medicine
Eligibility
Sex/Gender
Female
Inclusion criteria
Inclusion criteria: 1)Cancer, hematological disease, or collagen disease patients. 2)The physicians of primary disease make a written request for fertility preservation. 3)The patients who are expected long-term survival. 4)The patients who have the ability to provide written informed consent.
Exclusion criteria
Exclusion criteria: 1)The patients who are not expected long-term survival. 2)The patients who have the previous history of gynecologic malignant diseases (ovarian cancer, cervical adenocarcinoma) 3)The patients who are during the period of pregnancy or the possibility of pregnancy. 4)The patients judged to be inappropriate for the study by the physicians.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The recurrence of primary disease, Newborn anomalies and malformations | — |
Secondary
| Measure | Time frame |
|---|---|
| Oocytes retrieved, Fertilization rate, Ovarian reserve after treatment of primary disease | — |
Countries
Japan
Contacts
Public ContactNao Suzuki
St. Marianna University of Medicine Department of Obstetrics and Gynecology
Outcome results
None listed